Clinical Trial Update: Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing high versus low doses of losartan in heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Baker Heart and Diabetes Institute | Conditions: Heart Failure | Phase 4 | Status: WITHDRAWN